Antibody-mediated rejection criteria - an addition to the Banff 97 classification of renal allograft rejection.

TitleAntibody-mediated rejection criteria - an addition to the Banff 97 classification of renal allograft rejection.
Publication TypeJournal Article
Year of Publication2003
AuthorsRacusen LC, Colvin RB, Solez K, Mihatsch MJ, Halloran PF, Campbell PM, Cecka MJ, Cosyns J-P, Demetris AJ, Fishbein MC, Fogo A, Furness P, Gibson IW, Glotz D, Hayry P, Hunsickern L, Kashgarian M, Kerman R, Magil AJ, Montgomery R, Morozumi K, Nickeleit V, Randhawa P, Regele H, Seron D, Seshan S, Sund S, Trpkov K
JournalAm J Transplant
Volume3
Issue6
Pagination708-14
Date Published2003 Jun
ISSN1600-6135
KeywordsGraft Rejection, Humans, Kidney Transplantation
Abstract

Antibody-mediated rejection (AbAR) is increasingly recognized in the renal allograft population, and successful therapeutic regimens have been developed to prevent and treat AbAR, enabling excellent outcomes even in patients highly sensitized to the donor prior to transplant. It has become critical to develop standardized criteria for the pathological diagnosis of AbAR. This article presents international consensus criteria for and classification of AbAR developed based on discussions held at the Sixth Banff Conference on Allograft Pathology in 2001. This classification represents a working formulation, to be revisited as additional data accumulate in this important area of renal transplantation.

DOI10.1034/j.1600-6143.2003.00072.x
Alternate JournalAm J Transplant
PubMed ID12780562
Related Faculty: 
Surya V. Seshan, M.D.

Pathology & Laboratory Medicine 1300 York Avenue New York, NY 10065 Phone: (212) 746-6464
Surgical Pathology: (212) 746-2700